检索结果-南通市图书馆

Clinical application of DNA ploidy to cervical cancer screening: A review

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

World Journal of Clinical Oncology 2014年第5期5卷 931-965页

作者： david garner Integrative Oncology Department British Columbia Cancer Agency Vancouver V5Z 1L3 Canada

Screening for cervical cancer with DNA ploidy assessment by automated quantitative image cytometry has spread throughout China over the past decade and now an estimated 1 million tests per year are done there. Compared to conventional liquid based cytology, DNA ploidy has competitive accuracy with much higher throughput per technician. DNA ploidy has the enormous advantage that it is an objective technology that can be taught in typically 2 or 3 wk, unlike qualitative cytology, and so it can enable screening in places that lack sufficient qualified cytotechnologists and cytopathologists for conventional cytology. Most papers on experience with application of the technology to cervical cancer screening over the past decade were published in the Chinese language. This review aims to provide a consistent framework for analysis of screening data and to summarize some of the work published from 2005 to the end of 2013. Of particular interest are a few studies comparing DNA ploidy with testing for high risk human papilloma virus(hrH PV) which suggest that DNA ploidy is at least equivalent, easier and less expensive than hrH PV testing. There may also be patient management benefits to combining hr HPV testing with DNA ploidy. Some knowledge gaps are identified and some suggestions are made for future research directions.

关键词： Cervical cancer screening DNA ploidy Automated quantitative image cytometry High risk HPV testing

对《细胞DNA定量分析技术在宫颈癌筛查中的应用》一文的意见

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

现代肿瘤医学 2016年第1期24卷 168-170页

作者： david garner, PhD 陈湧彧大不列颠哥伦比亚肿瘤研究院不详

我刊本期在“读者·作者·编者”一栏刊登来自加拿大大不列颠哥伦比亚省肿瘤研究院（BCCA）肿瘤影像部高级研究员david garner教授（david garner教授为BCCA终身科学家，并负责该地区宫颈癌筛查项目质控，拥有多项专利并发表数百篇学术... 详细信息

我刊本期在“读者·作者·编者”一栏刊登来自加拿大大不列颠哥伦比亚省肿瘤研究院（BCCA）肿瘤影像部高级研究员david garner教授（david garner教授为BCCA终身科学家，并负责该地区宫颈癌筛查项目质控，拥有多项专利并发表数百篇学术文章）对本刊2015年23卷8期1116—1118页发表的陈涝或的论文《细胞DNA定量分析技术在宫颈癌筛查中的应用》一文的评论。期望通过这个平台，对本刊所刊发的文章进行讨论、争鸣、发表不同意见和见解，开展读者与作者间的交流互动，活跃学术气氛，以利于期刊在争鸣中增加论文的科学性、严谨性、创新性，从而正确引导和推动学科发展。医学研究常常需要大量的病例，并且涉及的影响因素较多，研究结果数据复杂，需要准确的统计分析才能得出正确的结论，同时论文作者应当重视每一数据的准确性，否则错误的结论则可能误导读者。现将david garner教授的来函及作者陈涝或的复函原文一并刊出，以飨读者。我们感谢david garner教授认真负责、一丝不苟的治学态度，同时对作者诚恳接受意见、认真对待，做出修正意见表示赞赏。

关键词：定量分析技术宫颈癌筛查 DNA 应用细胞论文作者学术气氛哥伦比亚省

Telecoms Mobile TV＇s Curtain Call

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

China International Business 2006年第8期 40-42页

作者： david HENDRICKSON

This year＇s World Cup was more than a showcase of the globe＇s top football stars. It also represented a coming out party of sorts for mobile television. According to Informa Telecoms ＆ Media, the 2006 World Cup was expected to garner upwards of US$300 million for the emerging mobile TV business, with millions of fanatics worldwide following the action by video streaming and packaged match highlights delivered to the palm of their hand.

关键词：手机电视电信服务中国市场需求数字电视

Computational cytometer based on magnetically modulated coherent imaging and deep learning

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Light(Science & Applications) 2019年第1期8卷 385-399页

作者： Yibo Zhang Mengxing Ouyang Aniruddha Ray Tairan Liu Janay Kong Bijie Bai Donghyuk Kim Alexander Guziak Yi Luo Alborz Feizi Katherine Tsai Zhuoran Duan Xuewei Liu Danny Kim Chloe Cheung Sener Yalcin Hatice Ceylan Koydemir Omai B.garner Dino Di Carlo Aydogan Ozcan Electrical and Computer Engineering Department University of CaliforniaLos AngelesCA 90095USA Department of Bioengineering University of CaliforniaLos AngelesCA 90095USA California NanoSystems Institute University of CaliforniaLos AngelesCA 90095USA Department of Physics and Astronomy University of ToledoToledoOH 43606USA Department of Physics and Astronomy University of CaliforniaLos AngelesCA 90095USA Yale School of Medicine New HavenCT 06510USA Department of Biochemistry University of CaliforniaLos AngelesCA 90095USA Department of Pathology and Laboratory Medicine University of CaliforniaLos AngelesCA 90095USA Department of Mechanical and Aerospace Engineering University of CaliforniaLos AngelesCA 90095USA Jonsson Comprehensive Cancer Center University of CaliforniaLos AngelesCA 90095USA Department of Surgery David Geffen School of MedicineUniversity of CaliforniaLos AngelesCA 90095USA

Detecting rare cells within blood has numerous applications in disease *** rare cell detection techniques are typically hindered by their high cost and low ***,we present a computational cytometer based on magnetically modulated lensless speckle imaging,which introduces oscillatory motion to the magneticbead-conjugated rare cells of interest through a periodic magnetic force and uses lensless time-resolved holographic speckle imaging to rapidly detect the target cells in three dimensions(3D).In addition to using cell-specific antibodies to magnetically label target cells,detection specificity is further enhanced through a deep-learning-based classifier that is based on a densely connected pseudo-3D convolutional neural network(P3D CNN),which automatically detects rare cells of interest based on their spatio-temporal features under a controlled magnetic *** demonstrate the performance of this technique,we built a high-throughput,compact and cost-effective prototype for detecting MCF7 cancer cells spiked in whole blood *** serial dilution experiments,we quantified the limit of detection(LoD)as 10 cells per millilitre of whole blood,which could be further improved through multiplexing parallel imaging channels within the same *** compact,cost-effective and high-throughput computational cytometer can potentially be used for rare cell detection and quantification in bodily fluids for a variety of biomedical applications.

关键词： rare magnetic speckle

Performance and calibration of quark/gluon-jet taggers using 140 fb^(-1) of pp collisions at √s=13 TeV with the ATLAS detector

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Chinese Physics C 2024年第2期48卷 1-25页

作者： G. Aad B. Abbott K. Abeling N.J. Abicht S.H. Abidi A. Aboulhorma H. Abramowicz H. Abreu Y. Abulaiti B.S. Acharya C. Adam Bourdarios L. Adamczyk S.V. Addepalli M.J. Addison J. Adelman A. Adiguzel T. Adye A.A. Affolder Y. Afik M.N. Agaras J. Agarwala A. Aggarwal C. Agheorghiesei A. Ahmad F. Ahmadov W.S. Ahmed S. Ahuja X. Ai G. Aielli A. Aikot M. Ait Tamlihat B. Aitbenchikh I. Aizenberg M. Akbiyik T.P.A. Åkesson A.V. Akimov D. Akiyama N.N. Akolkar K. Al Khoury G.L. Alberghi J. Albert P. Albicocco G.L. Albouy S. Alderweireldt M. Aleksa I.N. Aleksandrov C. Alexa T. Alexopoulos F. Alfonsi M. Algren M. Alhroob B. Ali H.M.J. Ali S. Ali S.W. Alibocus M. Aliev G. Alimonti W. Alkakhi C. Allaire B.M.M. Allbrooke J.F. Allen C.A. Allendes Flores P.P. Allport A. Aloisio F. Alonso C. Alpigiani M. Alvarez Estevez A. Alvarez Fernandez M. Alves Cardoso M.G. Alviggi M. Aly Y. Amaral Coutinho A. Ambler C. Amelung M. Amerl C.G. Ames D. Amidei S.P. Amor Dos Santos K.R. Amos V. Ananiev C. Anastopoulos T. Andeen J.K. Anders S.Y. Andrean A. Andreazza S. Angelidakis A. Angerami A.V. Anisenkov A. Annovi C. Antel M.T. Anthony E. Antipov M. Antonelli F. Anulli M. Aoki T. Aoki J.A. Aparisi Pozo M.A. Aparo L. Aperio Bella C. Appelt A. Apyan N. Aranzabal S.J. Arbiol Val C. Arcangeletti A.T.H. Arce E. Arena J-F. Arguin S. Argyropoulos J.-H. Arling O. Arnaez H. Arnold G. Artoni H. Asada K. Asai S. Asai N.A. Asbah J. Assahsah K. Assamagan R. Astalos S. Atashi R.J. Atkin M. Atkinson H. Atmani P.A. Atmasiddha K. Augsten S. Auricchio A.D. Auriol V.A. Austrup G. Avolio K. Axiotis G. Azuelos D. Babal H. Bachacou K. Bachas A. Bachiu F. Backman A. Badea P. Bagnaia M. Bahmani A.J. Bailey V.R. Bailey J.T. Baines L. Baines O.K. Baker E. Bakos D. Bakshi Gupta V. Balakrishnan R. Balasubramanian E.M. Baldin P. Balek E. Ballabene F. Balli L.M. Baltes W.K. Balunas J. Balz E. Banas M. Bandieramonte A. Bandyopadhyay S. Bansal L. Barak M. Barakat E.L. Barberio D. Barberis M. Barbero M.Z. Barel K.N. Barends T. Barillari M-S. Barisits T. Barklow P. Baron D.A. Baron Mo The ATLAS Collaboration

The identification of jets originating from quarks and gluons,often referred to as quark/gluon tagging,plays an important role in various analyses performed at the Large Hadron Collider,as Standard Model measurements and searches for new particles decaying to quarks often rely on suppressing a large gluon-induced *** paper describes the measurement of the efficiencies of quark/gluon taggers developed within the ATLAS Collaboration,using √s=13 TeV proton–proton collision data with an integrated luminosity of 140 fb^(-1) collected by the ATLAS *** taggers with high performances in rejecting jets from gluon over jets from quarks are studied:one tagger is based on requirements on the number of inner-detector tracks associated with the jet,and the other combines several jet substructure observables using a boosted decision tree.A method is established to determine the quark/gluon fraction in data,by using quark/gluon-enriched subsamples defined by the jet *** in tagging efficiency between data and simulation are provided for jets with transverse momentum between 500 GeV and 2 TeV and for multiple tagger working points.

关键词： ATLAS JET QUARK GLUON TAGGING